<DOC>
	<DOCNO>NCT02061969</DOCNO>
	<brief_summary>This study determine whether glycemic control , measure change HbA1c frequency hypoglycemia , different treatment linagliptin ( Tradjenta® ) basal insulin long term care resident ( LTC ) Type 2 diabetes ( T2D ) . Patients poorly control diabetes ( HbA1c &gt; 7.5 % ) randomize 6-month intervention linagliptin glargine insulin ( ± metformin treatment ) . Our hypothesis treatment linagliptin , daily DPP4-inhibitor , result similar improvement glucose control lower rate hypoglycemia insulin treatment LTC resident T2D . We also determine difference clinical outcome , resource utilization , hospitalization cost LTC resident T2D treat linagliptin basal correction insulin . We compare difference complication ( infectious non-infectious , neurological cardiovascular event ) , emergency room visit hospitalization group 6 month intervention .</brief_summary>
	<brief_title>ADA Linagliptin Long Term Care</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Linagliptin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>1 . Males female know history type 2 diabetes , treat diet , OADs monotherapy combination therapy ( exclude DPP4 inhibitor ) , slide scale insulin . 2 . Subjects HbA1c &gt; 7.5 % and/or blood glucose great equal 180 mg/dL 1 . Subjects history type 1 diabetes history diabetic ketoacidosis 2 . Treatment insulin GLP1 analogs past 3 month prior admission . 3 . Recurrent severe hypoglycemia hypoglycemic unawareness . 4 . Subjects history gastrointestinal obstruction gastroparesis . 5 . Patients acute chronic pancreatitis pancreatic cancer . 6 . Patients clinically significant hepatic disease ( cirrhosis , jaundice , endstage liver disease , portal hypertension ) elevate ALT AST &gt; 3 time upper limit normal , significantly impaired renal function ( GFR &lt; 45 ml/min ) . 7 . Treatment corticosteroid , parenteral nutrition immunosuppressive treatment . 8 . Mental condition render subject unable understand nature scope study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>nursing home facility</keyword>
	<keyword>long-term care facility</keyword>
	<keyword>old patient</keyword>
	<keyword>elderly patient</keyword>
	<keyword>hyperglycemia</keyword>
	<keyword>type 2 diabetes</keyword>
</DOC>